Drug intelligence / Profile preview

Huato Wharton's jelly mesenchymal stem cell injection

Development stage: Unknown
Lead developer: 深圳博雅感知药业
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intraarticular

Overview

Huato Wharton's jelly mesenchymal stem cell injection is an allogeneic cell therapy candidate developed by Shenzhen Boya Perception Pharmaceutical for the treatment of knee osteoarthritis. The product utilizes mesenchymal stem cells (MSCs) isolated from Wharton's jelly, the gelatinous tissue within the umbilical cord. These MSCs are characterized by their regenerative potential, including the ability to differentiate into chondrocytes and the secretion of paracrine factors that exhibit potent anti-inflammatory and immunomodulatory effects. Administered via a single intra-articular injection, the therapy is designed to modulate the joint microenvironment, alleviate pain, and potentially promote the repair of damaged articular cartilage in patients with degenerative joint disease.

Other names: Huato Wharton's jelly-derived mesenchymal stem cell injection

Beyond the preview

Go deeper on Huato Wharton's jelly mesenchymal stem cell injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huato Wharton's jelly mesenchymal stem cell injection.

Explore the full profile